We are live on ! Find out more
CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

109 hedge funds and large institutions have $1.44B invested in Clovis Oncology, Inc. in 2013 Q2 according to their latest regulatory filings, with 109 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+109
Holders Change %
% of All Funds
3.54%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
109
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CLVS Hedge Fund Activity: Q2 2013 in Review

109 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q2 2013, worth a combined $1.44B.

Buyers outnumbered sellers: 109 funds opened new CLVS positions and 0 closed out — a net gain of 109 holders — while 0 added to existing stakes and 0 trimmed.

  • 109 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.44B of Clovis Oncology, Inc. stock for Q2 2013.
  • 109 funds opened new Clovis Oncology, Inc. positions in Q2 2013 and 0 closed out, a net change of +109 holders.

Based on aggregated 13F filings for Q2 2013.